Biogen’s Q3 Aduhelm Sales Even Worse Than Expected

Executives Emphasize Low Expectations Through Year-End

 
• By Mandy Jackson
Success in business concept. Rising arrow and financial report.
Biogen's overall Q3 sales beat consensus, but expectations for Aduhelm are high • Source: Alamy

More from New Products

More from Scrip